Ahmet Bilici
- 4.6 優秀 • 473 レビュー
- 28年の経験
- トルコ, イスタンブール, Medipol Mega University Hospital
Dr. Ahmet Bilici は、腫瘍治療において 28年の経験 以上の経験を持つ著名な腫瘍内科医です。
- 肉腫および肺癌を専門とする
- メディポル・メガ大学病院に勤務
- トルコ屈指の腫瘍専門医として認められている
Dr. Ahmet Bilici は、腫瘍治療において 28年の経験 以上の経験を持つ著名な腫瘍内科医です。
クリストフ・ツィエリンスキー教授はウィーンの国際腫瘍学センターを率い、44年の経験にわたってオーストリアの現代腫瘍学の発展に貢献してきました。
エルケ・イェーガー教授はドイツトップクラスの腫瘍専門医であり、FOCUS評価に認定され、ノルトヴェスト・クリニックにおける肉腫治療を専門としています。
| EDUCATION | |
| |
| WORK EXPERIENCES & PRACTICES | |
| |
| OTHER EXPERIENCES | |
| 2015-2017 | Instructor nursing student at Sai noi hospital and Bangbuatong hospital |
| 2015 | Member of Pharmacy and Therapeutics Committee at Bangbuatong hospital |
| 2015 | Emergency Medicine, organized by Phramongkutklao hospital |
| 2016 | Update in internal medicine, organized by Siriraj hospital |
| 2016 | Ambulatory medicine, organized by Chulalongkorn-Ramathibodi-Siriraj hospita |
| 2016 | 5th ECG workshop, organized by Chulalongkorn hospital |
| ACADEMIC ACHIEVEMENTS | |
| Co-author in: Development and validation of a cancer-associated venous thromboembolism clinical risk prediction (CAT-CR) model >> waiting for publication | |
Dr. Dror Levin is a senior pediatrician and director of the blood disorder and bone cancer (sarcoma) treatment departments at Children's Hospital "Dana" and Medical Center "Sourasky" respectively. He is a specialist in pediatric medicine, hematology, and oncology, with additional experience studying abroad at the Rizzoli Orthopaedic Institute in Italy.
Dr. Michael Shapira is a specialist in Bone Marrow Transplantation with over 20 years of experience. He graduated from the Hebrew University Medical School in 1999. He completed his training in internal medicine at Hadassah Medical Center.
Dr. Shapira is a senior physician in the Bone Marrow Transplantation department at Hadassah. He has played a key role in many successful transplants and has helped maintain high patient survival rates. He is known for his clinical skills and commitment to improving transplantation medicine.
Dr. Herishanu Yair is a hematologist with 25 years of experience. He specializes in chronic lymphocytic leukemia (CLL). He is skilled in bone marrow transplantation, immunotherapy, CAR T-cell therapy, and leukemia chemotherapy.
Dr. Herishanu has received several awards, including the Young Investigator Research Prize, Clinical Excellence Prize, and Klitzberg Oncology Award. He has made important contributions to CLL research. His work includes many published studies and research grants from leading institutions.
He is a member of the Israeli and American Hematology Associations. This highlights his expertise and dedication to the field of hematology.
Adult Hematology
Fields of Study and Interests
• Stem cell transplantation (bone marrow transplantation:
autologous/allogeneic)
• Acute leukemias (AML-ALL)
• Chronic leukemias
• Lymphomas (Hodgkin and non-Hodgkin lymphomas)
• Multiple myeloma
• Bone marrow deficiencies (Myelodysplastic syndrome - aplastic anemia etc.)
• Chronic myeloproliferative diseases (polycythemia vera - essential thrombocytosis - primary
myelofibrosis)
• Anemias / Polycythemias (anemia - excess blood)
• Outpatient and inpatient chemotherapies - immunotherapies - targeted therapies
Education
• Faculty of Medicine – Cerrahpaşa Faculty of Medicine 1999-2005
• Internal Medicine Specialist Training – İstanbul Haseki Training and Research Hospital
20062010
• Hematology Subspecialist Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research
Hospital – Hematology and Stem Cell Transplantation Clinic 2013-2017
• Associate Professor İstanbul Ümraniye Training and Research Hospital 2019
Career
• Assistant Doctor Istanbul Haseki Training and Research Hospital-Internal Medicine Clinic
20062010
• Internal Medicine Specialist Istanbul Esenyurt State Hospital 2010-2012
• Internal Medicine Specialist-Military Service Samsun Military Hospital 2012-2013
• Minor Specialization Training Dr. Abdurrahman Yurtaslan Ankara Oncology Training and
Research Hospital – Hematology and Stem Cell Transplantation Clinic 2013-2017
• Hematology Subspecialist Ankara Gülhane Training and Research Hospital, Hematology and
Stem Cell Transplantation Clinic 2017-2018
• Hematology Subspecialist Istanbul Ümraniye Training and Research Hospital/Hematology
2018-2019
• Associate Professor Istanbul Ümraniye Training and Research Hospital/Hematology 2019-2021
• Associate Professor Maltepe University Faculty of Medicine / Hematology 2021-2024
• Associate Professor Istanbul VM Medical Park Pendik Hospital / Hematology and Stem Cell
Transplantation Clinic 2022-2024
Radiologist
Graduated (M.D. From)
Doctor of Medicine, Faculty of Medicine, Prince of Songkla University
Certificates
Certificate of Diagnostic Radiology, Faculty of Medicine, Prince of Songkla University
Current Positions
Diagnostic Radiologist at Intrarat Hospital
フォックス・ヴィオラ博士は、BKZゾーリンゲン血液腫瘍科・緩和医療科の主任医師です。同クリニックは、認定された集学的腫瘍センターです。フォックス博士は、ドイツおよびヨーロッパにおける腫瘍性疾患の薬物療法の第一人者であり、15年以上の臨床経験を有しています。
同博士は、ドイツ腫瘍学・血液腫瘍学会(GDHO)、ドイツ医師会、およびアメリカがん研究学会に所属しています。また、分子生物学の研究にも従事しており、その研究成果はがん治療および分子診断の発展に貢献しています。
主な専門領域は、化学療法、免疫療法、分子標的療法、および放射線療法です。フォックス博士は、革新的な治療法と患者への細やかな配慮で知られています。その取り組みにより、高い治癒率を達成し、同僚からの高い評価を得ています。
盧佩華博士は、米国および中国の両国でライセンスを取得した血液腫瘍内科の専門家であり、細胞免疫療法の先駆者です。北京医科大学を卒業後、米国で研鑽を積み、スタンフォード大学にて臨床フェローシップを修了、その後、米国国立衛生研究所(NIH)より二つの権威ある賞を受賞しました。中国における腫瘍浸潤リンパ球(CIK)細胞療法の最初の導入者の一人でもあります。2015年に帰国後は、CAR-T療法および血液がん治療の発展を牽引してきました。盧博士は、中国非公立医療機関協会血液病委員会委員長を含む10以上の医療関連組織において指導的役割を担っています。また、「医療管理賞」や「年間最優秀人民医師」など、国家レベルの表彰も受けています。
診療科:血液内科・リンパ腫&骨髄腫センター
Dr. Axel Stang is a professor, Head Physician of Asklepios Barmbek Clinic, with a specialization in internal medicine, oncology, and hematology. He conducts antibody and molecular therapies to reduce tumor size, and is a member of multiple organizations and societies. Dr. Stang has published articles on the effectiveness of radiofrequency ablation in treating of metastatic colon cancer, and was a member of a research group that studied the effects of liver embolization. Patients can submit a request on the Bookimed website to get a consultation with the professor.